Corcept Therapeutics
Focus: Corcept Therapeutics is a small-molecule biotech focused on endocrine and oncology disorders, with a market presence centered on its flagship Cushing's syndrome therapy. The company operates at mid-cap scale (201-500 employees) from Redwood City, California.
Profile data last refreshed 19h ago · AI intelligence enriched 2w ago
Employees
201-500
Open Jobs
0
About Corcept Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Corcept Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
50 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$229M Part DStable
Peak12.2yr
Sole revenue engine with 14-year exclusivity runway; accounts for 100% of company revenue.
Help build intelligence for Corcept Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.